Clinical Trial Update: A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma

View source ↗

Summary

This entry describes a registry study for BRCA mutation carriers with pancreatic ductal adenocarcinoma, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pancreatic Ductal Adenocarcinoma | Status: ACTIVE_NOT_RECRUITING